Adrenal D-Stress
On sale on the US market (according to the DSLD)
Patient One 1 MediNutritionals, food supplement from the US market
Adrenal D-Stress (Patient One 1 MediNutritionals), a food supplement au code-barres 853959004014, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. Doses of vitamine A are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Declared dose above a limit
Vitamine C: up to 250 mg a day according to the label (at most 1 serving a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Patient One 1 MediNutritionals
- Barcode
- 853959004014
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Rice Flour, Vegetable Cellulose, Leucine
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin A | Vitamin | 1,500 µg |
| Vitamin C | Vitamin | 250 mg |
| Thiamine | Vitamin | 25 mg |
| Vitamin B-6 | Vitamin | 25 mg |
| Zinc | Mineral | 15 mg |
| Pregnenolone | Hormone | 10 mg |
| Pantethine | Vitamin | 50 mg |
| Dehydroepiandrosterone | Hormone | 5 mg |
| Sensoril Ashwagandha (Withania somnifera) | Plant | 250 mg |
| Relora | Blend | 500 mg |
| Magnolia officinalis extract | Plant | not stated |
| Phellodendron amurense bark extract | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Adrenal D-Stress
Entered into DSLD on 24 July 2019. Withdrawn from the US market on 26 March 2021 (according to the DSLD).Same active composition.
Official label: Adrenal D-Stress
Entered into DSLD on 23 December 2016. Withdrawn from the US market on 28 February 2019 (according to the DSLD).- Active ingredient added : Magnolia officinalis (quantity not stated)
- Active ingredient added : Phellodendron amurense (quantity not stated)
- Active ingredient removed : Magnolia officinalis extract (quantity not stated)
- Active ingredient removed : Phellodendron amurense bark extract (quantity not stated)
- Different unit, without conversion : Vitamin A: 5,000 IU in this version; 1,500 mcg on the displayed label
Official label: Adrenal D-Stress
Entered into DSLD on 24 July 2015. Withdrawn from the US market on 20 September 2016 (according to the DSLD).- Active ingredient added : Magnolia officinalis (quantity not stated)
- Active ingredient added : Phellodendron amurense (quantity not stated)
- Active ingredient removed : Magnolia officinalis extract (quantity not stated)
- Active ingredient removed : Phellodendron amurense bark extract (quantity not stated)
- Different unit, without conversion : Vitamin A: 5,000 IU in this version; 1,500 mcg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sensoril Ashwagandha
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Patient One 1 MediNutritionals
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Adrenal D-Stress (Patient One 1 MediNutritionals): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/853959004014-adrenal-d-stress-patient-one-1-medinutritionals, updated 22 April 2021.